Correlation Between First-line Immunotherapy and Second-line TKI Outcomes in Metastatic Renal Cell Carcinoma.

Saved in:
Bibliographic Details
Title: Correlation Between First-line Immunotherapy and Second-line TKI Outcomes in Metastatic Renal Cell Carcinoma.
Authors: Sugimoto K; Department of Urology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan., Minami T; Department of Urology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan., Nukaya T; Department of Urology, Fujita Health University School of Medicine, Toyoake, Japan., Maenosono R; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Japan., Tsujino T; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Japan., Mori K; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Yanagisawa T; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Yamanoi T; Department of Urology, Faculty of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, Okayama, Japan., Nishimura S; Department of Urology, Faculty of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, Okayama, Japan., Takahara K; Department of Urology, Fujita Health University School of Medicine, Toyoake, Japan., Fujita K; Department of Urology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan., Group OBOTJS; Department of Urology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan.; Department of Urology, Fujita Health University School of Medicine, Toyoake, Japan.; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Japan.; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.; Department of Urology, Faculty of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Source: Cancer diagnosis & prognosis [Cancer Diagn Progn] 2025 Oct 30; Vol. 5 (6), pp. 735-740. Date of Electronic Publication: 2025 Oct 30 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 9918316186306676 Publication Model: eCollection Cited Medium: Internet ISSN: 2732-7787 (Electronic) Linking ISSN: 27327787 NLM ISO Abbreviation: Cancer Diagn Progn Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2732-7787
DOI:10.21873/cdp.10488